Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study

Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study

Abstract Background We aimed to identify motivators for people who inject drugs to pursue treatment for hepatitis C virus (HCV) infection and uncover opportunities that could make treatment more appealing. Methods Between November 2023 and January 2024, we conducted semi-structured interviews with 1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Phyo Aung, Margaret Hellard, Paul Dietze, Bek Petrovic, Peter Higgs, Mark Stoové
Format:	Article
Language:	English
Published:	BMC 2024-12-01
Series:	Harm Reduction Journal
Subjects:	Practical solutions Hepatitis C treatment Behaviour change People who inject drugs Motivators
Online Access:	https://doi.org/10.1186/s12954-024-01136-1
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identifying barriers to hepatitis B and delta screening, prevention, and linkage to care among people who use drugs in Philadelphia, Pennsylvania, USA
by: Beatrice Zovich, et al.
Published: (2024-11-01)

Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection
by: Gyde Steffen, et al.
Published: (2024-12-01)

Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics?
by: Thomas J. Stopka, et al.
Published: (2025-01-01)

Disproportionate, differential and targeted treatment: people who use drugs’ experiences of policing during the COVID-19 pandemic
by: Shelley Walker, et al.
Published: (2025-01-01)

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study
by: Fernando Chacón, et al.
Published: (2024-11-01)

A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You’re Empowered for Treatment Initiation (YETI) partner trial
by: Meghan D. Morris, et al.
Published: (2025-01-01)

Predictors of future overdose among people who inject drugs in Baltimore, Maryland
by: Michael P. Ramirez, et al.
Published: (2024-12-01)

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
by: Mojca Maticic, et al.
Published: (2024-11-01)

Achieving Hepatitis C Micro-Elimination in Chinese Injecting Drug Users: A Dynamic Network Modeling Study
by: Ying Chen, et al.
Published: (2024-12-01)

Depressive symptoms and determinants among people who inject drugs in Kaduna State, Nigeria
by: Nuhu N. Butawa, et al.
Published: (2024-11-01)

Findings from a Project Which Established Hepatitis C Point-of-Care Testing and Linkage to Care at a Homelessness Service in Adelaide, Australia, 2021–2022
by: Erin M. McCartney, et al.
Published: (2024-12-01)

HCV and HIV co-infection among people who inject drugs in Vietnam
by: Vu Toan THINH, et al.
Published: (2020-12-01)

Is San Diego California on Track to Reach HCV Elimination? A Modeling Analysis of Combination Prevention Strategies
by: Jaskaran S. Cheema, et al.
Published: (2024-11-01)

Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital
by: Hallie Rozansky, et al.
Published: (2024-11-01)

HCV Treatment Outcomes in PWID: Impact of Addiction History on SVR12
by: Ivana Milošević, et al.
Published: (2024-12-01)

Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD
by: Tarfa Verinumbe, et al.
Published: (2024-12-01)

Centering autonomy and choice to support oral PrEP utilization among people who inject drugs: qualitative lessons from HPTN 094 INTEGRA
by: Amaya Perez-Brumer, et al.
Published: (2024-12-01)

Applying population‐specific incidence prevalence ratio benchmarks to monitor the Australian HIV epidemic: an epidemiological analysis
by: Jonathan M. King, et al.
Published: (2024-12-01)

A novel, multi-component contingency management intervention in the context of a syndemic of drug-related harms in Glasgow, Scotland: First year of the ‘WAND’ initiative
by: S. Smith, et al.
Published: (2025-06-01)

A large-scale screening of hepatitis C among men who have sex with men in the community using saliva point-of-care testing
by: Sonia Albertos, et al.
Published: (2024-12-01)

People who use drugs and the right to health
by: Alison Ritter, et al.
Published: (2024-12-01)

Barriers to uptake of harm reduction techniques for GBMSM who use drugs in night-clubs and sex-on-premises venues in London and the Southeast: a mixed-methods, qualitative study
by: Stephen Naulls, et al.
Published: (2025-02-01)

Total burden of hepatitis B and C attributed to injecting drug use in 204 countries and territories from 1990 to 2021: Analyses based on the Global Burden of Disease Study 2021
by: Liang Huang, et al.
Published: (2025-01-01)

Resolved Hepatitis B: Achieved or Imaginary Wellbeing?
by: S. N. Batskikh
Published: (2021-04-01)

Assessment of harm reduction receipt and infectious diseases outcomes in United States Veterans with opioid use disorder and history of injection drug use
by: Khushbu P. Shah, et al.
Published: (2024-11-01)

Improving hospital care for people who use drugs: deliberative process development of a clinical guideline for opioid withdrawal management
by: Marisha Wickremsinhe, et al.
Published: (2024-11-01)

Fatal poisonings in Nordic countries in 2022 among people who use drugs
by: Pirkko Kriikku, et al.
Published: (2025-07-01)

Hepatitis C virus infection among non-IDU HIV-infected and uninfected men who have sex with men.
by: Massimo Giuliani, et al.
Published: (2011-11-01)

Hepatitis C virus infection among non-IDU HIV-infected and uninfected men who have sex with men.
by: Fabrizio Ensoli, et al.
Published: (2011-01-01)

Pesticide Injection and Drenching
by: Frederick Fishel, et al.
Published: (2022-05-01)

A Systematic Literature Review on SQL Injection Attacks
by: Maryam Mehmood, et al.
Published: (2024-02-01)

Human immunodeficiency virus prevention and testing strategies among men who have sex with men in the UK: the PANTHEON research programme including the SELPHI RCT
by: Janey Sewell, et al.
Published: (2024-10-01)

A cross-sectional study of stigma towards opioid users among rural law enforcement and community members in tennessee
by: Kahler W. Stone, et al.
Published: (2024-11-01)

Factors associated with utilization of mobile health clinic hepatitis C virus services among medically underserved communities in South Carolina
by: Kerry A. Howard, et al.
Published: (2024-12-01)

Application of Ultrasound Classification of Hepatic Hydatid Cyst in Iraqi Population
by: Inas M. Al-Ani, et al.
Published: (2020-06-01)

Pesticide Injection and Drenching
by: Frederick M. Fishel
Published: (2018-01-01)

Pesticide Injection and Drenching
by: Frederick M. Fishel
Published: (2018-01-01)

Self-reported lifetime Hepatitis B virus testing, and vaccination uptake among people who inject drugs in Iran: a nationwide study in 2020
by: Maliheh Sadat Bazrafshani, et al.
Published: (2024-11-01)

INDONESIA’S EFFORT TO MEET WHO RECOMMENDATION ON EXCLUSIVE BREASTFEEDING 2012-2023
by: Fazah Amalia Nabilah, et al.
Published: (2024-07-01)

COVID-19 in India: Health implications and treatment needs of people who use drugs (PWUD) and patients with substance use disorders (SUD)
by: Gautam Kr GHOSH
Published: (2020-07-01)